Amplify Weight Loss Drug & Treatment ETF (THNR) Chart & Stock Price History $22.76 -0.48 (-2.07%) (As of 12/20/2024 04:33 PM ET) Add Compare Share Share Chart Stock AnalysisChartHoldingsOwnershipRatings Amplify Weight Loss Drug & Treatment ETF Stock Price Performance 5 Day Performance-3.72%1 Month Performance-1.68%3 Month Performance-16.95%6 Month Performance-12.37% Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… THNR Stock Chart for Sunday, December, 22, 2024 THNR Chart by TradingView Amplify Weight Loss Drug & Treatment ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$23.24$22.76-2.07%$22.99$22.722,097 shs$0.0012/19/2024$23.38$23.24-0.60%$23.24$23.10656 shs$0.0012/18/2024$24.00$23.38-2.58%$23.87$23.321,326 shs$0.0012/17/2024$23.64$24.00+1.52%$24.00$24.00124 shs$0.0012/16/2024$23.67$23.64-0.11%$23.72$23.64392 shs$0.0012/13/2024$23.84$23.67-0.71%$23.69$23.531,213 shs$0.00 Get the Latest News and Ratings for THNR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$24.09$23.84-1.04%$24.01$23.841,307 shs$0.0012/11/2024$24.01$24.09+0.33%$24.09$24.03879 shs$0.0012/10/2024$24.37$24.01-1.48%$24.45$24.016,420 shs$0.0012/09/2024$24.31$24.37+0.27%$24.37$24.37411 shs$0.0012/06/2024$24.15$24.31+0.66%$24.33$24.20453 shs$0.0012/05/2024$24.22$24.15-0.29%$24.19$24.141,187 shs$0.0012/04/2024$24.19$24.22+0.12%$24.27$24.221,757 shs$0.0012/03/2024$24.02$24.19+0.71%$24.28$24.19487 shs$0.0012/02/2024$24.02$24.02$24.02$23.93940 shs$0.0011/29/2024$23.84$24.02+0.76%$24.02$23.82856 shs$0.0011/28/2024$23.84$23.84-0.01%$23.84$23.69503 shs$0.0011/27/2024$23.67$23.84+0.72%$23.84$23.69503 shs$0.0011/26/2024$23.66$23.67+0.04%$23.70$23.601,708 shs$0.0011/25/2024$23.36$23.66+1.26%$23.66$23.444,652 shs$0.0011/22/2024$23.15$23.36+0.91%$23.43$23.322,631 shs$0.0011/21/2024$23.00$23.15+0.65%$23.22$23.15476 shs$0.0011/20/2024$22.87$23.00+0.57%$23.16$22.993,981 shs$0.00 Related Companies Xtrackers US Green Infrastructure Select Equity ETF Stock Chart SmartETFs Sustainable Energy II ETF Stock Chart iShares Health Innovation Active ETF Stock Chart iShares Emergent Food and AgTech Multisector ETF Stock Chart First Trust S-Network Streaming and Gaming ETF Stock Chart Hypatia Women CEO ETF Stock Chart Veridien Climate Action ETF Stock Chart AdvisorShares Hotel ETF Stock Chart ProShares Ultra Nasdaq Cybersecurity ETF Stock Chart iShares Neuroscience and Healthcare ETF Stock Chart Receive THNR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amplify Weight Loss Drug & Treatment ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:THNR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
